Skip to main content

VivoSim (NASDAQ: VIVS) — Human 3D Tissue Models & Drug Toxicity

Research: Vivosim inc.
On behalf of Vivosim Inc.

NASDAQ VIVS Profile & Technology Overview

VivoSim (NASDAQ: VIVS) is developing human-relevant 3D tissue models designed to improve pharmaceutical decision-making by helping researchers evaluate drug toxicity, efficacy, and safety earlier in the development process.

Stay Ahead Of The Drug Development Shift

VivoSim Inc. (NASDAQ: VIVS) helps pharma identify drug toxicity earlier with human-relevant 3D tissue models.

 Form will be replace with beehiiv form